Company / Capital Expenditures
Beneficient Capital Expenditures History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$1.8M
FY2025
5-year range
$1.8M / $3.2M
FY2023-FY2025
Trend
-15.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $3M to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025.
Declined from $3M to $2M over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capital expenditures decreased 15.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -23.61 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.8M | -15.3% |
| FY2024 | $2.1M | -35.5% |
| FY2023 | $3.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026